Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mediwound Ltd Ord Sh (MDWD)

Mediwound Ltd Ord Sh (MDWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mediwound Ltd Ord Sh 42 HAYARKON STREET YAVNE L3 8122745 ISR

www.mediwound.com Employees: 111 P: 972-77-971-4100 F: 972-779-7141

Sector:

Medical

Description:

MediWound Ltd. is a biotechnology niche specialty company. It is focused on developing, manufacturing and commercializing products that address unmet needs in the fields of severe burn and chronic wound management. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. is headquartered in Yavne, Israel.

Key Statistics

Overview:

Market Capitalization, $K 211,207
Enterprise Value, $K 202,047
Shares Outstanding, K 11,087
Annual Sales, $ 20,220 K
Annual Net Income, $ -30,220 K
Last Quarter Sales, $ 5,430 K
Last Quarter Net Income, $ -2,650 K
EBIT, $ -23,560 K
EBITDA, $ -22,080 K
60-Month Beta 0.07
% of Insider Shareholders 9.20%
% of Institutional Shareholders 46.83%
Float, K 10,067
% Float 90.80%
Short Volume Ratio 0.29

Growth:

1-Year Return 11.40%
3-Year Return 87.68%
5-Year Return -28.38%
5-Year Revenue Growth -36.40%
5-Year Earnings Growth -523.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 11/20/25
Next Earnings Date 03/18/26
Earnings Per Share ttm -1.90
EPS Growth vs. Prev Qtr 80.49%
EPS Growth vs. Prev Year 75.51%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 12/20/22

MDWD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.11%
Return-on-Assets % -27.12%
Profit Margin % -149.46%
Debt/Equity 0.02
Price/Sales 10.56
Price/Cash Flow N/A
Price/Book 4.26
Book Value/Share 4.52
Interest Coverage -1.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar